5 Things You Need to Consider to Achieve Success in Europe (feat. Phoenix Group)

As a Virtual Pharma company, your primary focus is on the science and finding new ways to meet existing and unmet medical needs. However, there are important steps you need to follow to bring your product to market and achieve success. Commercialising your product relies on how effectively you can leverage what the relevant domain experts can offer. Hear how we’ve successfully supported, from strategy to sustainability, a range of biotech/startups with their market entry in Europe.

Date/Time: September 2 @ 11AM EST (4PM BST)

Presenters:

  • Christoph Krähenbühl – Senior Director (Excellis Europe)
  • Stefan Pflug – Head of Corporate Pharma Services & Sourcing (PHOENIX Group)

This webinar will help you identify what to focus on to achieve success based on our deep subject matter expertise.

To view a copy of the recording, please click here.


 

SIP & SECURE Happy Hour webinar feat. Rich Kaeser (J&J)

Date/Time: August 20 @ 3PM EST

Guest Speaker: Rich Kaeser, Vice President of Global Brand Protection (Johnson & Johnson)

Host: Sean O’Hearen, former Brand Protection consultant (Johnson & Johnson); Subject Matter Expert (Excellis Health Solutions)

Counterfeiting is now the largest criminal enterprise in the world, accounting for more than 3% of global trade. In the first episode of this series, we will talk with Rich Kaeser from Johnson & Johnson about what brand owners should be thinking to keep your products safe and secure for your customers.

To view a copy of the recording, click here.


SIP & SERIALIZE – Serialization as Brand Protection

Date/Time: August 6 @ 3PM EST
Guest Speaker: Sean O’Hearen (former Johnson & Johnson Brand Protection consultant)

You have Serialized and you have complied with DSCSA, but what if your product(s) need more to be truly protected against counterfeiting and diversion? It is vital that every organization understands the operational and reputational threats that illicit trade poses and how to guard against it. As we conclude with the last episode of Sip & Serialize, we will discuss what Brand Protection is and how it differentiates from Serialization.


 

5 Things to Consider as a Virtual Pharma Company

As a Virtual Pharma company, your primary focus is on the science and finding new ways to meet existing and unmet medical needs; however, there are important steps you need to follow to bring your product to market and achieve success. Commercialising your product successfully relies on how effectively you can leverage what the relevant domain experts can offer.

Presenters:

  • Christoph Krähenbühl – Senior Director (Excellis Europe)
  • Stefan Pflug – Head of Corporate Pharma Services & Sourcing (PHOENIX Group)

This webinar will help you identify what to focus on to achieve success based on our deep subject matter expertise.


 

SIP & SERIALIZE – Aggregation feat. Apace Packaging

New topic: Aggregation

Date: July 9

Guest Speaker: Apace Packaging

This webinar discussed:

  • Aggregation
    • Now vs. Later?
    • What is the impact to internal operations?
    • What is the impact across the supply chain?
  • Rip & Replace
    • Is having multiple solution providers risk mitigation or risk exposure?
    • What makes a good contingency plan?
    • What are key considerations regarding upgrade and maintenance vs. replacement or consolidation?

To view the recording, please click here.


 

Brexit & Pharma: Get expert advice on how to remain in control

This webinar discussed:

  • What system(s), if any, will manufacturers need to connect to from 2021 onward for the UK?
  • What will be the obligations regarding EU-FMD and serialised packs for the UK market from 1st January 2020?
  • How does this impact UK Packs shared with other markets, such as Ireland, Malta, and Cyprus?

Presenters

  • Jerome Bertin: GM at SecurMed UK, the UK NMVO
  • Grainne Hughes: VP of Business Support Operations at Almac Group
  • Christoph Krähenbühl: Senior Director at Excellis Europe

View the recording HERE.


 

5 Things to Know Before Going to Market in the EU

Date: June 10

Excellis Europe has a proven serialization track record with over 150 projects launched, 200 pack lines qualified, 50+ go-lives, 500+ CMOs/3PLs onboarded and 92 validation projects.

We will reveal the five things virtual pharma need to know about getting their product into the European market.

To view a copy of this Webinar, please click HERE.


 

SIP & SERIALIZE – Nov. 27 deadline feat. AmerisourceBergen

Date: May 28

Guest Speaker: AmerisourceBergen

Are you prepared for November 27? Have you determined the best approach that will positively impact the stakeholders within and outside of your organization? Is your company aware of the relative costs, implementation complexities, manual efforts, and data security considerations for each potential solution?

To view a copy of this Webinar, please click HERE.